Back
Vaxcyte Vs. Merck & Industry Stock Comparison
Sell
19
PCVX
Vaxcyte
Last Price:
$83.22
Seasonality Move:
-7.08%
Sell
27
MRK
Merck &
Last Price:
$98.84
Seasonality Move:
0.73%
Sell
27
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
-
MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCVX Stock Price Chart
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.38 | Sell |
Relative Strength Index (14 RSI): | 32.65 | Sell |
Chaikin Money Flow: | 69834 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.12 - 92.52) | Sell |
Bollinger Bands (100): | (84.39 - 112.63) | Sell |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 46.53 | Sell |
Chaikin Money Flow: | 5915908 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.14 - 102.3) | Sell |
Bollinger Bands (100): | (100.55 - 114.85) | Sell |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 84.55 | Sell |
20-day SMA: | 87.87 | Sell |
50-day SMA: | 95.34 | Sell |
200-day SMA: | 84.88 | Sell |
8-day EMA: | 84.18 | Sell |
20-day EMA: | 87.32 | Sell |
50-day EMA: | 92.68 | Sell |
200-day EMA: | 86.47 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.23 | Buy |
20-day SMA: | 100.5 | Sell |
50-day SMA: | 101.09 | Sell |
200-day SMA: | 117.29 | Sell |
8-day EMA: | 99.4 | Buy |
20-day EMA: | 100.02 | Sell |
50-day EMA: | 102.38 | Sell |
200-day EMA: | 111.56 | Sell |
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.82 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.76 per share, and an increase next year of $0.94 per share.
Vaxcyte Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |